Trial Profile
A phase Ia/b study of oral formulation of CR845 for the treatment of acute and chronic pain in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2015
Price :
$35
*
At a glance
- Drugs Difelikefalin (Primary)
- Indications Acute pain; Pain
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 27 Jun 2014 New trial record
- 18 Jun 2014 According to a Cara Therapeutics media release, top-line pharmacokinetic, safety and biomarker data is expected in the fourth quarter of 2014.